Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)

SHA:688658 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,009	1,333	1,483	1,661	2,437	2,536
Trading Asset Securities	345.71	160.26	-	-	-	-
Cash & Short-Term Investments	1,354	1,493	1,483	1,661	2,437	2,536
Cash Growth	-15.40%	0.72%	-10.76%	-31.84%	-3.88%	542.35%
Accounts Receivable	584.45	805.43	1,094	1,366	927.02	669.43
Other Receivables	13.87	10.67	1.58	0.22	2.28	15.93
Receivables	598.32	816.1	1,095	1,366	929.3	685.36
Inventory	477.3	757.34	727.69	738.34	632.31	626.6
Other Current Assets	98.77	91.33	119.24	135.64	66.91	44.48
Total Current Assets	2,529	3,158	3,425	3,901	4,066	3,892
Property, Plant & Equipment	2,041	1,999	1,960	1,671	1,302	1,314
Long-Term Investments	145.4	33.1	15.75	-	-	-
Other Intangible Assets	165.24	175.01	174.32	174.68	181.14	134.04
Long-Term Deferred Tax Assets	37.78	30.32	20.39	17.82	12.35	8.95
Long-Term Deferred Charges	304.35	293.89	270.65	194.9	97.87	87.25
Other Long-Term Assets	7.21	48.57	45.5	49.34	67.81	20.61
Total Assets	5,230	5,738	5,911	6,009	5,727	5,457
Accounts Payable	506.03	559.34	592.05	711.18	771.73	747.4
Accrued Expenses	46.21	556.47	891.65	725.52	655.5	546.92
Short-Term Debt	72.99	112.97	351.77	228.35	9.01	160.24
Current Portion of Long-Term Debt	291.68	51.67	16.84	-	-	-
Current Portion of Leases	-	9.23	10.34	9.68	4.77	41.37
Current Income Taxes Payable	42.95	0.51	16.41	1.02	57.03	26.71
Current Unearned Revenue	16.72	44.54	29.68	57.09	40.03	73.86
Other Current Liabilities	398.58	170.77	227.89	166.51	144.13	182.67
Total Current Liabilities	1,375	1,506	2,137	1,899	1,682	1,779
Long-Term Debt	299.91	516.97	54.57	-	-	-
Long-Term Leases	4.73	14.46	29.38	39.72	23.77	-
Long-Term Unearned Revenue	119.43	116.21	93.05	72.32	93.7	91.93
Total Liabilities	1,799	2,153	2,314	2,011	1,800	1,871
Common Stock	450	450	450	450	450	450
Additional Paid-In Capital	2,645	2,645	2,645	2,681	2,645	2,645
Retained Earnings	434.5	582.47	547.65	857.86	828.56	485.75
Treasury Stock	-100.02	-100.02	-54.99	-	-	-
Total Common Equity	3,430	3,578	3,588	3,989	3,924	3,581
Minority Interest	0.8	7.33	9.8	8.09	3.38	4.97
Shareholders' Equity	3,430	3,585	3,598	3,997	3,927	3,586
Total Liabilities & Equity	5,230	5,738	5,911	6,009	5,727	5,457
Total Debt	669.32	705.31	462.91	277.75	37.55	201.61
Net Cash (Debt)	685	787.86	1,020	1,384	2,400	2,334
Net Cash Growth	-22.34%	-22.73%	-26.31%	-42.34%	2.81%	-
Net Cash Per Share	1.54	1.78	2.26	3.05	5.32	6.49
Filing Date Shares Outstanding	444.48	444.48	447.18	450	450	450
Total Common Shares Outstanding	444.48	444.48	447.18	450	450	450
Working Capital	1,154	1,652	1,288	2,002	2,384	2,113
Book Value Per Share	7.72	8.05	8.02	8.87	8.72	7.96
Tangible Book Value	3,264	3,403	3,414	3,815	3,743	3,447
Tangible Book Value Per Share	7.34	7.66	7.63	8.48	8.32	7.66
Buildings	-	1,417	1,314	1,127	1,135	1,102
Machinery	-	1,203	1,166	958.27	871.85	799.61
Construction In Progress	-	539.86	470.99	458.45	74.95	107.77

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.